Kevin Wang, Dr.
Executive Director
All Sessions by Kevin Wang, Dr.
3:40 pm
-
4:00 pm
S11 .01 - Studying the Biomarker Trajectory in Preclinical TBI Models; Lesson learning from the TOP-NT Consortium Project.
5:15 pm
-
7:00 pm
POB.14 - Toward Clinical Implementation of Blood Biomarkers for Traumatic Brain Injury: Analytical Harmonization and Reference Standard Development in the INFORM-TBI Consortium
5:15 pm
-
7:00 pm
POB.71 - Beyond Glasgow Coma Scale: Applying the Comprehensive Brain Injury Model to Pediatric Traumatic Brain Injury
5:15 pm
-
7:00 pm
POB.158 - Fc-Engineered Monoclonal Antibodies Targeting neoGFAP™ as a Disease-Modifying Immunotherapy for Traumatic Brain Injury
4:30 pm
-
6:30 pm
POA.09 - Longitudinal Monitoring of Capillary Blood Biomarkers in Traumatic Brain Injury: A Dried Plasma Spot Pilot Study
4:30 pm
-
6:30 pm
POA.10 - Mechanistically Anchored Trajectories of neoGFAP™ as a Blood Biomarker for Adult Traumatic Brain Injury Monitoring: A Single-Site Cohort Pilot Study
4:30 pm
-
6:30 pm